Altman Peter 4
4 · BioCardia, Inc. · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
BioCardia (BCDA) CEO Peter Altman Receives Award; Shares Withheld
What Happened Peter Altman, President, CEO and a director of BioCardia (BCDA), did not sell stock in the open market. On July 2, 2026, 54,606 shares were withheld by the company to cover income tax/withholding obligations related to RSUs that vested June 29, 2026 (reported disposal value $67,711). On July 6, 2026, Altman was reported to have been granted 57,688 derivative shares (no cash paid), which will vest over time.
Key Details
- Transaction dates and amounts:
- July 2, 2026 — 54,606 shares withheld (Disposition) at $1.24 per share; total reported value $67,711 (tax withholding; not an open-market sale) [F1].
- July 6, 2026 — 57,688 derivative shares granted at $0.00 (award/derivative) [A].
- Shares owned after the transactions: not disclosed in the provided filing excerpt.
- Footnotes:
- F1: Shares were withheld by the issuer to satisfy income tax/withholding obligations from the RSU net settlement (not a market sale).
- F2: The granted derivative vests 1/48th monthly beginning August 6, 2026, subject to continued service.
- Filing: Form 4 filed July 7, 2026 for a July 2 report date — this appears to fall within the normal Form 4 reporting window.
Context This filing reflects routine equity compensation administration (RSU net settlement and a new award) rather than an open-market purchase or sale. The July 2 "disposition" is a tax-withholding event tied to vested RSUs, not an indicator that the insider sold shares on the market. The July 6 grant is a time‑based derivative award (vesting monthly), so the reported grant does not represent immediately tradable common shares.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-07-02$1.24/sh−54,606$67,711→ 356,585 total - Award
Stock Option (right to buy)
[F2]2026-07-06+57,688→ 147,903 totalExercise: $1.20Exp: 2036-07-06→ Common stock (57,688 underlying)
Footnotes (2)
- [F1]The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person.
- [F2]The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.